Professor Loïc Lang-Lazdunski
MD, PhD, FRCS (Eng), Consultant Thoracic Surgeon
Professor Loïc Lang-Lazdunski was born in France, he graduated from Xavier Bichat Medical School, Paris in 1991 and trained in General Surgery and Cardiothoracic Surgery in Paris. He was awarded an MD in 1996 and a PhD in experimental surgery in 2000.
He spent a year working as a post-doctoral research fellow at Harvard Medical School / Massachusetts General Hospital and was a visiting fellow at several prestigious cardiothoracic units including Massachusetts General Hospital, Brigham and Women Hospital, in Boston and Methodist Hospital-Baylor College of Medicine, Houston to get additional training in Thoracic Surgical Oncology.
He was appointed as Assistant Professor of Cardiothoracic Surgery at Paris University in November 1998 and held consultant positions in two major university hospitals in Paris until 2002. He was appointed a Consultant Thoracic Surgeon at Guy’s and St Thomas’ Hospital NHS Foundation Trust in 2003. He was promoted to Professor of Thoracic Surgery at King’s College, London in 2012.
Mr Lang-Lazdunski has a special interest in malignant pleural mesothelioma, lung cancer and other thoracic malignancies. He has led the program in malignant pleural mesothelioma at Guy’s Hospital, one of the busiest in Europe, since his appointment.
He has an interest in extended resections for advanced-stage lung cancer including tracheal resections, great vessels resections and major chest wall resections, and also mediastinal tumours such as thymomas or germ cell tumours.
He has developed a large activity in the field of lung resection and metastasectomy for secondary lung cancer. Mr Lang-Lazdunski is a recognised expert in minimally invasive and Video-Assisted Thoracic Surgery (VATS) and has developed a program of VATS lobectomy and segmentectomy for early stage lung cancer and VATS resection of mediastinal tumours at Guy’s Hospital. Mr Lang-Lazdunski has an interest in congenital chest wall malformations, tumours and infections in children and adults.
He is involved in clinical and basic research in the field of malignant mesothelioma, lung cancer and other thoracic malignancies. He is an investigator or principal investigator in several international trials in the field of mesothelioma or lung cancer.
Professor Lang-Lazdunski has accumulated a large experience with these operations and our anaesthetists and critical care physicians are used to look after patients following these complex procedures. In the past 15 years we have not had any mortality after P/D in more than 150 patients. This is the lowest mortality reported worldwide. More than 95% of our patients were able to receive chemotherapy or / and targeted therapy after surgery and the vast majority of them returned to normal activities after a few weeks.
Professor Lang-Lazdunski has made presentations or contributed to research presented at the European Lung Cancer Conference 2018 in Geneva, International Mesothelioma Interest Group Meeting 2018 in Ottawa, American Society of Clinical Oncology Meeting 2018 in Chicago and European Society of Thoracic Surgeons Meeting 2018 in Lubjana. He collaborates with promiment colleagues worldwide to improve the prognosis and quality of life of patients living with mesothelioma. He has played a key role in the Mesothelioma and Radical Surgery (MARS) trial, operating more patients than any other surgeon in the study. He has published several landmark articles in the past 15 years, which have influenced the way doctors treat mesothelioma. His work has contributed to American Society of Clinical Oncology (ASCO) recognising and recommending radical surgery in its 2018 guideline for patients with malignant pleural mesothelioma. He helps surgeons and oncologists set up mesothelioma programs worldwide and is regularly invited to lecture at prestigious international meetings. He is the leading mesothelioma surgeon in the UK and in Europe and his outcomes are second to none.
He has published more than 100 scientific articles in the field of cardiothoracic surgery and has made many presentations at national and international meetings. He is a regular reviewer for the Journal of Thoracic and Cardiovascular Surgery, the Annals of Thoracic Surgery and the European Journal of Cardiothoracic Surgery and serves on several national and international scientific committees.
Professor Loïc Lang-Lazdunski is an active member of several learned societies including the European Association for Cardiothoracic Surgery, the European Society of Thoracic Surgeons, the Society for Cardiothoracic Surgery in Great Britain and Ireland, the British Thoracic Society, the British Thoracic Oncology Group, the International Association for the Study of Lung Cancer and the International Mesothelioma Interest Group.